Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -5685.74% is 539% below its 5-year average of -890.19%, around the middle of its 5-year range (-8368.31%–-139.41%).
330.21% below its 12-month average of -1321.62%.
Reported quarterly EBITDA margin; no daily interpolation. Q1 FY2024 (2024-03-31): -1807.67%.
EBITDA MARGIN
-5685.74%
EBITDA MARGIN AVG TTM
-1321.62%
EBITDA MARGIN AVG 3Y
-3893.12%
EBITDA MARGIN AVG 5Y
-890.19%
EBITDA MARGIN AVG 10Y
-251.58%
EBITDA MARGIN AVG 15Y
-251.39%
EBITDA MARGIN AVG 20Y
-291.08%
CURRENT VS TTM AVG
-330.21%
CURRENT VS 3Y AVG
-46.05%
CURRENT VS 5Y AVG
-538.71%
CURRENT VS 10Y AVG
-2159.98%
CURRENT VS 15Y AVG
-2161.68%
CURRENT VS 20Y AVG
-1853.33%
Soligenix, Inc.
Market Cap
$5.31M
EBITDA Margin
-5685.74%
TTM Avg
-1321.62%
3Y Avg
-3893.12%
5Y Avg
-890.19%
Market Cap
$5.32M
EBITDA Margin
-2579.35%
TTM Avg
-2579.35%
3Y Avg
-2089.74%
5Y Avg
-2089.74%
Market Cap
$5.35M
EBITDA Margin
-1670.57%
TTM Avg
-1446.66%
3Y Avg
-2067.25%
5Y Avg
-1679.39%
Market Cap
$5.24M
EBITDA Margin
-271.50%
TTM Avg
-294.22%
3Y Avg
-453.19%
5Y Avg
-366.18%
Market Cap
$5.22M
EBITDA Margin
-123.71%
TTM Avg
-161.92%
3Y Avg
-255.04%
5Y Avg
-225.97%
Market Cap
$5.21M
EBITDA Margin
-8.85%
TTM Avg
9.13%
3Y Avg
18.32%
5Y Avg
18.32%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Soligenix, Inc. (SNGX) | $5.31M | -5685.74% | -1321.62% | -3893.12% | -890.19% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.32M | -2579.35% | -2579.35% | -2089.74% | -2089.74% |
| Lexaria Bioscience Corp. (LEXX)vs › | $5.35M | -1670.57% | -1446.66% | -2067.25% | -1679.39% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.24M | -271.50% | -294.22% | -453.19% | -366.18% |
| Pulmatrix, Inc. (PULM)vs › | $5.22M | -123.71% | -161.92% | -255.04% | -225.97% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.21M | -8.85% | 9.13% | 18.32% | 18.32% |
| Alzamend Neuro Inc (ALZN)vs › | $5.21M | N/A | N/A | N/A | N/A |
| Lunai Bioworks Inc. (LNAI)vs › | $5.12M | N/A | N/A | N/A | N/A |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | N/A | N/A | N/A | N/A |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $4.97M | N/A | N/A | N/A | N/A |
Gross Margin
0.0%
EBITDA Margin
-5685.7%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2024-03-31 | -1807.67% |
| 2023-03-31 | -835.57% |
| 2022-12-31 | -1783.48% |
| 2022-03-31 | -8368.31% |
| 2021-03-31 | -6670.59% |
| 2020-12-31 | -1916.71% |
| 2020-09-30 | -354.04% |
| 2020-06-30 | -956.05% |
| 2020-03-31 | -1000.51% |
| 2019-12-31 | -579.51% |
| 2019-09-30 | -219.28% |
| 2019-06-30 | -139.41% |
| 2019-03-31 | -199.83% |
| 2018-12-31 | -309.98% |
| 2018-09-30 | -138.16% |
| 2018-06-30 | -115.34% |
| 2018-03-31 | -306.55% |
| 2017-12-31 | -198.45% |
| 2017-09-30 | -52.23% |
| 2017-06-30 | -231.91% |
| 2017-03-31 | -129.02% |
| 2016-12-31 | -74.92% |
| 2016-09-30 | -49.90% |
| 2016-06-30 | -31.24% |
| 2016-03-31 | -71.58% |
| 2015-12-31 | -73.50% |
| 2015-09-30 | -31.11% |
| 2015-06-30 | -179.39% |
| 2015-03-31 | -183.52% |
| 2014-12-31 | -117.97% |
| 2014-09-30 | -182.19% |
| 2014-06-30 | -115.35% |
| 2014-03-31 | -167.79% |
| 2013-12-31 | -101.06% |
| 2013-09-30 | -576.94% |
| 2013-06-30 | -426.86% |
| 2013-03-31 | -114.57% |
| 2012-12-31 | -180.65% |
| 2012-09-30 | -74.70% |
| 2012-06-30 | -121.99% |
| 2012-03-31 | -213.72% |
| 2011-12-31 | -221.55% |
| 2011-09-30 | 39.04% |
| 2011-06-30 | -463.01% |
| 2011-03-31 | -206.88% |
| 2010-12-31 | -773.65% |
| 2010-09-30 | -196.28% |
| 2010-06-30 | -346.51% |
| 2010-03-31 | -622.51% |
| 2009-12-31 | -33.18% |
| 2009-09-30 | -210.61% |
| 2009-06-30 | -527.07% |
| 2009-03-31 | -399.02% |
| 2008-12-31 | -52.10% |
| 2008-09-30 | -72.91% |
| 2008-06-30 | -254.41% |
| 2008-03-31 | -198.03% |
| 2007-12-31 | -376.07% |
| 2007-09-30 | -285.71% |
| 2007-06-30 | -571.36% |
| 2007-03-31 | -936.12% |
| 2006-09-30 | -1122.65% |
| 2006-06-30 | -2394.98% |
| 2006-03-31 | -119.55% |
| 2005-12-31 | -280.28% |
| 2005-09-30 | -154.83% |
| 2005-08-12 | -38.24% |
| 2005-03-31 | -865.84% |
| 2004-12-31 | -193.83% |
| 2004-03-31 | -1568.81% |
